---
layout: post
title: "Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments; Extension of Comment Period"
date: 2026-02-05 18:58:40 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-06762
original_published: 2022-03-31 00:00:00 +0000
significance: 8.00
---

# Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments; Extension of Comment Period

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 31, 2022 00:00 UTC
**Document Number:** 2022-06762

## Summary

The Food and Drug Administration (FDA, we, or Agency) is extending the comment period for the notice of public hearing that appeared in the Federal Register of January 13, 2022. In the notice, FDA requested comments on scientific data and information related to the residue of carcinogenic concern for the new animal drug carbadox. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/31/2022-06762/scientific-data-and-information-related-to-the-residue-of-carcinogenic-concern-for-the-new-animal)
- API: https://www.federalregister.gov/api/v1/documents/2022-06762

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
